MOLECULAR CHARACTERIZATION AND IN-SITU LOCALIZATION OF MURINE ENDOGLIN REVEAL THAT IT IS A TRANSFORMING GROWTH-FACTOR-BETA BINDING-PROTEIN OF ENDOTHELIAL AND STROMAL CELLS
S. Stjacques et al., MOLECULAR CHARACTERIZATION AND IN-SITU LOCALIZATION OF MURINE ENDOGLIN REVEAL THAT IT IS A TRANSFORMING GROWTH-FACTOR-BETA BINDING-PROTEIN OF ENDOTHELIAL AND STROMAL CELLS, Endocrinology, 134(6), 1994, pp. 2645-2657
Endoglin is an integral membrane glycoprotein predominantly expressed
on human endothelial cells and recently shown to bind transforming gro
wth factor-beta 1 (TGF beta 1) with high affinity. We now report the c
loning and sequencing of a full-length murine endoglin complementary D
NA of 2902 base pairs which hybridizes specifically with a single mess
enger RNA (mRNA) species. The polypeptide of 653 amino acids has an ov
erall identity of 72% with human and porcine endoglin. The transmembra
ne and cytoplasmic domains of all three proteins differ by two to four
amino acids and are 70% identical to the corresponding regions of the
TGF beta binding protein, betaglycan. Relative levels of murine endog
lin mRNA were estimated by polymerase chain reaction and found to be h
igh in ovary and uterus, intermediate in heart and muscle, and low in
placenta and spleen. In situ hybridization and immunofluorescence conf
irmed that murine endoglin, like its human counterpart, is present in
blood vessels and capillaries in all tissues examined. In addition, th
e stromal cells in the connective tissue of intestine, stomach, heart,
muscle, uterus, ovary, and testis were strongly and specifically reac
tive with complementary RNA probes and with a polyclonal antibody to e
ndoglin; epithelial cell layers were distinctly unreactive. This distr
ibution is. similar to that of extracellular TGF beta 1, particularly
in heart and uterus, and suggests that endoglin on stromal fibroblast-
like cells might be regulating access of TGF beta 1 to the signaling r
eceptor complex. NCTC-2071 fibroblasts in culture were shown to expres
s high levels of endoglin mRNA by polymerase chain reaction. After che
mical cross-linking with [I-125]TGF beta 1 and immuneprecipitation wit
h the polyclonal antihuman endoglin serum, a radiolabeled band of mel
wt 180,000 corresponding to dimeric endoglin was observed under nonred
ucing conditions, whereas a single band of mol wt 90,000 was seen unde
r reducing conditions. Thus murine fibroblast endoglin is capable of b
inding TGF beta 1. Future studies should establish the specialized rol
e of endoglin in the TGF beta receptor complex of endothelial and stro
mal cells.